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Evan E. Eichler2,3,*The highest andmost prestigious honor that The American
Society of Human Genetics (ASHG) can bestow on any sci-
entist is the William Allan Award. This honor is awarded
each year in memory of William Allan to a scientist who
has had far-reaching and substantial scientific contribu-
tions to the field of human genetics and who has thus
demonstrated a sustained period of productivity over their
lifetime. William Allan was a physician, an educator, and
one of the early pioneers of American human genetics. It
is a special treat for me today to introduce to you the 2013
recipient of this award: Aravinda Chakravarti.
In 1954 in Calcutta, Aravinda was born the third son in a
family who placed a high value on the importance of edu-
cation. He was a particularly precocious child but even at a
young age never shied away from voicing his opinion. He
received his Bachelor of Statistics in 1974 from the Indian
Statistical Institute, Calcutta, and immigrated to the
United States, where in 1979 he received his Ph.D. while
working with Masatoshi Nei at the University of Texas.1This article is based on the address given by the author at themeeting of The A
MA, USA. The audio of the original address can be found at the ASHG website
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the Department of Human Genetics at the University of
Pittsburgh; he joined the faculty of Case Western Reserve
University in 1994 and later the Johns Hopkins University
School of Medicine in 2000. He is currently the director
of the Center for Complex Disease Genomics of the
McKusick-Nathans Institute of Genetic Medicine and a
professor of medicine, pediatrics, and molecular biology
and genetics at Johns Hopkins.
Aravinda’s contributions to science have shown a
remarkablebreadthanddepth.Hehasmade seminal contri-
butions to the discovery of the gene associated with cystic
fibrosis,1 to the characterization of one of the first genomic
disorders (Charcot-Marie-Tooth disease type 1A),2 and to
our fundamental understanding of the patterns of linkage
disequilibrium3,4 and genetic variation.5 His work on
Hirschsprung disease has highlighted the importance of ge-
netic variation irrespective of class (common or rare), type
(point or structural mutation), or location (coding or non-
coding).6–9 It has served as a remarkable model for gaining
insight into the genetic basis of complexdisease.His unique
contributions have stemmed from his recognition of the
power of combining population genetics with advances in
genomic technology to solve problems ofmedical genetics.
His guiding principles have always been straightforward:
‘‘The fields of human and medical genetics simply cannot
exist without a fundamental understanding of genetic vari-
ation.’’10 He has firmly believed that understanding the
nature and pattern of this genetic variation is the key to un-
locking the potential power of our field. He recognized early
on that sequencing is the ultimate geneticmap and that sys-
tematic high-throughput sequencing and genotyping are
thekeys tounderstanding the genetic architectureofhuman
disease. He predicted that the 21st century would belong to
ourfieldonce thesewereachieved, that technologies focused
on characterizing the patterns of genetic variation would
make our species the ‘‘model organism’’ for understanding
disease, and that our next task should be directed toward
determining how that genetic variation leads to biology.
His contributions have gone far beyondhis own research.
Aravinda has always had a clear view of the big picture and
has played a critical role in catalyzing and shapingmany of
the initiatives that have transformed our field over the lastmerican Society of HumanGenetics (ASHG) onOctober 25, 2013, in Boston,
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30 years. Such initiatives include the HumanGenome Proj-
ect, the HapMap Project, and the 1000 Genomes Project.
His commitment to ASHG and the field of human genetics
at large has been exemplary. He was a member of the Board
of Directors from 1996 to 1998 and the Awards Committee
in 2002 and was president of ASHG in 2008; he has been a
long-standing editor of the journal Genome Research and
co-editor of Annual Review of Genomics and Human Genetics
since2004; andhehas servedonnumerousnational and in-
ternational advisory boards over the last 20 years. The
opinion of few human geneticists has been held in such
high regard. If you ever organized a meeting, Aravinda
was the one person you would want to be present. Gregar-
ious bynature, Aravindawould catalyze discussion andpro-
pel an idea to the next level. Continuing on long after a
session would end, conversations would often move to
the pub and beyond. More than just being a visionary, he
has recognized the importance of getting down into the
trenches and sorting out the details.
Although he is a prolific scientific writer, some of you
might not know that one of his earliest works was a cook-
book published in 1978: Not Everything We Eat Is Curry: A
Bengali Guide to Indian Cuisine. Aravinda has a deep and
profound sense of the history of the field of human ge-
netics. His heroes are numerous—R.A. Fisher, Sewal
Wright, J.B.S Haldane—and he has a passion for reading
and owning their original works. Juxtaposing Aravinda’s
sense of history is his strong conviction that the future
of our field lies in the hands of the younger generation.
Not surprisingly, he has a long and productive track record
of mentorship. As of 2013, he has mentored over 20 Ph.D.
students, 32 postdocs, 12 Master’s students, and numerous
undergrads and clinical fellows. Many of his former stu-
dents and former postdocs, who are in the audience today,
are now leaders in their own right and active members of
ASHG. Although he did not always agree with his trainees,
I was always impressed that he made a conscious effort to
stop and listen to their point of view. One of the highlights
of those working in his lab was the Friday ‘‘beer hours,’’
where he would invite his lab to go to the local pub to
discuss science and society.
In closing, permitme to sharemy ownpersonal anecdote
regarding Aravinda. Although I was never his student or
postdoc trainee, I have always regarded Aravinda as one of
the most influential mentors of my scientific career.
When I joined the faculty of Case Western Reserve Univer-
sity in 1997, there were in fact two: Hunt Willard and
Aravinda Chakravarti. Although the advice given from
these two was often diametrically opposed, I was deeply
appreciative of their different perspectives. Aravinda in
particular was persuasive. I have always been impressed
with his knack for placing one’s research into a broader sci-
entific context and for identifying the inherent flaws or
weaknesses in a proposal. There is a unique charm and wit
to Aravinda’s arguments—hewould often start a discussion
with ‘‘That’s fine, but can I tell you something?’’ or ‘‘There
are two issues here!’’ You would then brace yourself for aThe Amelong discussion. Inevitably, when I would reflect on the
advice given, I would realize that there were many, many
more than just two issues—occasionally one butmore often
three, four, or five important points. Whenever Aravinda
had something to say, it required a multifactorial analysis.
On behalf of ASHG, let me thank you for your scientific
contributions, your insight, and your leadership over the
years. Your passion for human genetics has added color
and enrichment to our science. You have been an inspira-
tion and an example to an entire generationof young scien-
tists and educated an older generation on the power of
statistics and the population-genetics framework. Your
commitment to integrating population genetics, genome
technology, andmedicine has transformed our field. Ladies
and gentleman, please join me in welcoming the 2013
recipientof theWilliamAllanAward:AravindaChakravarti.References
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